BGLC BioNexus Gene Lab Corp: institutional ownership and insider trading
3 funds reported holding $27.2K of BioNexus Gene Lab Corp in their latest 13F filings; in Q2 2026 funds net bought $27.6K, with 2 new positions and 1 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Largest institutional holders of BGLC
- HRT FINANCIAL LP — $27.0K
- UBS Group AG (UBS) — $197
- Caitong International Asset Management Co., Ltd — $2
5%+ owners
- Fidelion Diagnostics Pte. Ltd.: 13.4% (Schedule 13G, filed Oct 22, 2026)
- Tan Lee Su-Leng: 11.5% (Schedule 13D, filed Aug 14, 2026)